ArticleJournal of drug assessment2019

Long-term safety and efficacy of rupatadine in Japanese patients with perennial allergic rhinitis: a 52-week open-label clinical trial.

Kimihiro Okubo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.